//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
De #EuropeseUnie lanceert gecentraliseerde #HTA met haar eerste gezamenlijke klinische beoordeling (#JCA) van #Ojemda (#tovorafenib) voor pediatrische hersentumoren. www.ipharmacenter.com/post/eu-laun... #Nieuws #Pharma #Oncologie #MarketAccess #Gezondheidszorg #Regulatory #Biotech
1d
The European Commission has published its inaugural Joint Clinical Assessment (JCA), officially activating the EU’s modernized Health Technology Assessment (HTA) framework under Regulation (EU) 2021/2...
www.ipharmacenter.com
EU Launches Era of Centralized HTA with First Joint Clinical Assessment of Ojemda | iPharmaCenter